Invasive group B streptococcal disease in infants: a 19-year nationwide study. Serotype distribution, incidence and

K Ekelund1, H B Konradsen

  • 1Streptococcus Unit, Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, Copenhagen, Denmark. kej@ssi.dk

Insights

Invasive group B streptococcal (GBS) infections in Danish infants remain a concern, with serotype III being most common. Recurrent GBS infections occurred in 1% of infants, with identical serotypes in repeat cases.

Area of Science:

  • Microbiology
  • Pediatrics
  • Epidemiology

Background:

  • Invasive group B streptococcal (GBS) disease poses a significant threat to neonates.
  • Understanding GBS epidemiology, serotype distribution, and recurrence is crucial for prevention and treatment.

Purpose of the Study:

  • To analyze the incidence, serotype distribution, and recurrence patterns of invasive GBS disease in Danish infants from 1984-2002.

Main Methods:

  • Retrospective analysis of 472 invasive GBS cases in infants aged 0-90 days in Denmark.
  • Serotyping of GBS isolates and Pulse Field Gel Electrophoresis (PFGE) for recurrent cases.
  • Assessment of antibiotic susceptibility for paired isolates.

Main Results:

  • Overall GBS incidence was 0.4/1000 live births, with 73% being early-onset infections.
  • Serotype III predominated (59%), followed by Ia (16%) and Ib (8%).
  • Six infants (1%) experienced recurrent GBS infections, with identical serotypes and indistinguishable isolates between episodes.

Conclusions:

  • Invasive GBS infections continue to be a public health issue in Denmark.
  • Recurrent GBS infections in infants are uncommon but occur with consistent serotypes.
  • Further research into GBS prevention and management strategies is warranted.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...